G-CSF administration in acute MI patients was feasible, did not lead to any clinical or angiographic adverse events and resulted in CD34+ and CD34+ AC133+ VEGFR2+ cell mobilization.
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans
FERRARI, Roberto;
2007
Abstract
G-CSF administration in acute MI patients was feasible, did not lead to any clinical or angiographic adverse events and resulted in CD34+ and CD34+ AC133+ VEGFR2+ cell mobilization.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.